New research reveals that tiny amounts of PFAS-widely known as "forever chemicals"-cross the placenta and breast milk to alter infants' developing immune systems, potentially leaving lasting imprints ...

Mantle cell lymphoma treatment offers options if patients relapse after CAR T-cell therapy, from bispecific antibodies, antibody drug conjugates, and other emerging therapies.

Arvinas Inc. (NASDAQ:ARVN) is one of the best low priced pharma stocks to buy now. Earlier on June 13, Arvinas presented ...

Imugene Limited (ASX: IMU), a clinical-stage immuno-oncology company, is pleased to announce exciting new data from its Phase ...

At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the ...

A robust clinical development programme for Lunsumio is ongoing, investigating the molecule as a monotherapy and in combination with other medicines, for the treatment of people with B-cell ...

Single-cell sequencing reveals heterogeneous B cell subsets, including plasma cells, follicular B cells, and cytotoxic "killer B cells," each with distinct roles.

Single-cell sequencing reveals heterogeneous B cell subsets, including plasma cells, follicular B cells, and cytotoxic "killer B cells," each with distinct roles. For instance, germinal center (GC) ...

Single-cell sequencing reveals heterogeneous B cell subsets, including plasma cells, follicular B cells, and cytotoxic "killer B cells," each with distinct roles.

During the follicular B‐cell response, B cells interact with other immune cells, such as follicular‐dendritic cells or follicular helper‐T cells, to undergo antigen affinity maturation, such as SHM, ...